Should You Buy Jamieson Wellness at These Levels?

Jamieson Wellness could be a lower risk defensive bet facing this uncertain economic outlook.

| More on:
Happy diverse people together in the park

Image source: Getty Images

Last year was tough on global equity markets, as high inflation, rising interest rates, and ongoing geopolitical tensions weighed on investors’ sentiments, thus dragging stock prices down. The Canadian benchmark index, the S&P/TSX Composite Index, fell 8.7%. Amid the weakness in the broader equity markets, Jamieson Wellness (TSX:JWEL) lost around 10.9% of its stock value last year.

However, the leading health supplements brand has been delivering solid returns since going public in July 2017. Despite the recent pullback, JWEL stock has been trading 130% higher since its public debut. So, given its impressive track record, should investors utilize the pullback to accumulate the stock? Let’s first look at its performance in the recently reported third quarter.

Jamieson Wellness third-quarter performance

Despite the challenging market conditions, Jamieson Wellness has continued on its growth trajectory, with its topline growing by 23.6%. The contribution from the recent acquisition of Nutrawise Health & Beauty Corporation and solid organic growth drove its sales during the quarter. In July 2022, the company acquired Nutrawise Health & Beauty, which produces and markets premium supplements under the youtheory brand across the United States and international markets. The acquisition contributed around $17.5 million, or 20.6% of its incremental revenue.

Amid the topline growth, the company’s gross profits increased by $7.7 million. However, its normalized gross profit margin declined by 1.4% to 34.9% due to an unfavourable product mix and higher depreciation expenses due to Nutrawise’s acquisition. The company’s SG&A (selling, general, and administrative) expenses also increased by $11.6 million to $30.9 million due to acquisition-related expenses and IT system development and implementation costs.

Consequently, net earnings declined by 23.8% to $10.9 million. However, removing one-time items, adjusted net earnings increased by 1.2% to $14.2 million. Adjusted EPS (earnings per share) remained flat at $0.34. Meanwhile, the company utilized $20.6 million of its cash for its operations during the quarter, closing the quarter with a cash balance of $7.3 million.

Now, let’s look at its growth prospects.

Jamieson Wellness outlook

Jamieson Wellness manufactures, distributes, and markets high-quality natural products worldwide. With the aging population and growing consumer awareness about self-care, the demand for the company’s products could continue to rise. Besides, the acquisition of Nutrawise Health & Beauty has strengthened the company’s presence in the United States VSM (vitamins, minerals, and supplements) market.

Additionally, the global supplements brand announced in November that it had agreed to acquire certain tangible and intangible assets from its distribution partner in China. The company expects the acquisition to provide more control over its sales, marketing, and distribution activities in China. With China being the second-largest vitamin market in the world, the acquisition could allow the company to expand its footprint in the country. So, Jamieson’s growth prospects look healthy.

Bottom line

Last month, the Federal Reserve of the United States stated that it would continue with its monetary tightening measures. With central banks focusing on fighting inflation, the Centre for Economics and Business Research projects a recession this year. So, given the economic uncertainty, investing in a highly defensive healthcare stock, such as Jamieson Wellness, would be an excellent move. At present, the company trades at an attractive valuation, with its NTM (next 12 months) price-to-earnings multiple standing at 20.1.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Doctor talking to a patient in the corridor of a hospital.
Investing

TFSA: Healthcare Dividend Stocks Are Perfect for Passive Income

Top healthcare dividend stocks like Extendicare Inc. (TSX:EXE) and others can provide huge passive income in your TFSA.

Read more »

TFSA and coins
Tech Stocks

TFSA: Invest in These 2 Stocks for a Legit Chance at $1 Million

Are you interested in building a $1 million portfolio? Invest $20,000 in these two stocks!

Read more »

edit Person using calculator next to charts and graphs
Investing

The Top TSX Stock on My Watch List Right Now

Here's why Alimentation Couche-Tard (TSX:ATD) remains a top TSX stock that long-term investors seeking growth and yield will want to…

Read more »

Hourglass projecting a dollar sign as shadow
Investing

3 Stocks to Add to Your TFSA ASAP

Given their stable cash flows and solid underlying businesses, these three stocks are excellent additions to your TFSA in this…

Read more »

edit Person using calculator next to charts and graphs
Dividend Stocks

Better Buy: Fortis Stock vs Enbridge

Fortis stock and Enbridge are top dividend stocks on the TSX today. Which stock is better buy for safe dividend…

Read more »

Canadian Dollars
Dividend Stocks

How to Make $1,500 in Passive Income 4 Times a Year

Blue-chip TSX stocks such as Enbridge can enable investors to create game-changing wealth over the long term.

Read more »

Woman has an idea
Investing

5 Stocks You Can Confidently Invest $500 in Right Now

Consider putting your surplus cash in these stocks for stellar capital gains.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

TFSA: How to Easily Turn $10,000 Into $500/Year of Passive Income

You don't need to be a stock market expert to turn $10,000 into a $500 of tax-free passive income. Here's…

Read more »